The Benchmark Company Announces Closing of Public Offering of $5m for Seelos Therapeutics, Inc.
13 févr. 2020 15h51 HE
|
The Benchmark Company, Llc
NEW YORK, Feb. 13, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company today announced the closing of an Underwritten Public Offering for Seelos Therapeutics, Inc. of 6,666,667 shares of common stock at...